openPR Logo
Press release

Blepharitis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results

04-08-2019 03:26 PM CET | Health & Medicine

Press release from: Pharma Proff

Blepharitis Therapeutics- Pipeline Analysis 2018, Clinical

Blepharitis is an inflammatory disorder of eyelids and can be categorized into two types; anterior and posterior blepharitis. The inflammation at the outside front of the eyelid is anterior blepharitis, whereas, inflammation at the inner eyelid is posterior blepharitis.

Download the sample report @ https://www.pharmaproff.com/request-sample/1055

The major complications associated with blepharitis are the sty (acute infection of oil glands in eye), chalazion (painless lump due to inflammation of oil glands in eye), and the problem with tear film.

Get the detailed analysis @ https://www.pharmaproff.com/report/blepharitis-therapeutics-pipeline-analysis

Some of the symptoms observed in the patients with blepharitis are excessive tearing, itching, burning sensation, swollen eyelids, eye redness, and blurred vision.

Make enquiry before @ https://www.pharmaproff.com/enquiry/1055

Nicox SA is in the process of developing NCX4251 as a glucocorticoid receptor agonist for the treatment of blepharitis. InSite Vision Incorporated is in the process of developing ISV-305 as a glucocorticoid receptor agonist for the treatment of blepharitis.

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Blepharitis Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results here

News-ID: 1693483 • Views: 230

More Releases from Pharma Proff

Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates. IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates. Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Pate …
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome. Download the sample report at: https://www.pharmaproff.com/request-sample/1189 Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances

All 5 Releases


More Releases for Blepharitis

Blepharitis Market Competitive Healthcare Assessment 2018 to 2025
Global Blepharitis Market Research Report 2018 tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Blepharitis market. This research report offers in-depth analysis of the market size (revenue), market share, major market segments, and different
Blepharitis Treatment Market Trends, Outlook, and Opportunity Analysis, 2018-202 …
Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of
Blepharitis Treatment Market Opportunity Analysis, 2018-2026
Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of
Blepharitis Market Display Significant Growth by 2025
Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly
Blepharitis Market Projected to be Resilient During 2017 - 2025
Blepharitis is a chronic condition that is caused by chronic inflammation of the eyelid. It is a common eye disorder that is caused either by bacterial infection or skin condition (dandruff on scalp or acne rosacea). This is not a contagious disease condition and generally does not cause a permanent damage to the eye. Blepharitis is a common eye condition that leads the eyelid to redden, swollen and appears scaly
Blepharitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Blepharitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Blepharitis - Pipeline Review, H2 2017, provides an overview of the Blepharitis (Ophthalmology) pipeline landscape. Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin,